Astrana Health closes deal with Prospect Health at a lower price

 

• Astrana Health (NASDAQ:ASTH) announced on Wednesday that it has completed the acquisition of Prospect Health, with a deal price of $708M, down from the previously stated $745M.
• In light of the anticipated contributions from Prospect over the next six months, Astrana is revising its revenue projections for the full year 2025.
• The company now expects total revenue to fall between $3.1B and $3.3B, with adjusted EBITDA anticipated to range from $215M to $225M.
• Astrana said it is reaffirming its guidance for the second quarter of 2025.

https://www.msn.com/en-us/money/markets/astrana-health-closes-deal-with-prospect-health-at-a-lower-price/ar-AA1HPJgP